Phio PharmaceuticalsPHIO
13F holders, Q4 2024 (December 31)11holders +5
6new positions
2sold out
1famous investor
$1.80avg. 13F price*
At the end of Q4 2024, 11 institutions reported holding Phio Pharmaceuticals Corp. (PHIO) in their 13F filings, up 5 from Q3 2024. 6 opened new positions and 2 sold out. The largest holders were Citadel Advisors ($80K), HRT Financial LP ($76K) and Virtu Financial LLC ($74K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Phio Pharmaceuticals Corp.
- CUSIP
- 71880W501
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $265K |
| Exits | 2 | $88K |
All 13F filers, Q3 2024 → Q4 2024: 151,108 shares bought and 25,631 shares sold, net +125,477 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Citadel Advisors | 0.00% | New | 44,526 | $80K |
| HRT Financial LP | 0.00% | New | 42,338 | $76K |
| Virtu Financial LLC | 0.00% | New | 40,910 | $74K |
| Cetera Investment Advisers | 0.00% | New | 13,000 | $23K |
| Morgan Stanley | 0.00% | New | 5,911 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +298.8% | 4,682 | $8K |
| UBS Group AG | 0.00% | Add +42.3% | 2,397 | $4K |
| Barclays PLC | 0.00% | New | 203 | $365 |
| SBI Securities Co., Ltd. | 0.00% | — | 63 | $113 |
| Activest Wealth Management | 0.00% | No change | 9 | $16 |
| Bank of America Corp. | 0.00% | No change | 7 | $13 |
"% of holder's portfolio" is PHIO's weight in each manager's 13F, not the share of Phio Pharmaceuticals Corp. the manager owns.